泰安市部署药品安全监测能力提升工作

Core Viewpoint - The meeting held on June 9-10 in Tai'an focused on enhancing drug safety monitoring capabilities, highlighting the achievements and future strategies for improving drug safety in the region [1][2]. Group 1: Achievements - The drug safety monitoring evaluation in Tai'an has shown positive results, with 9 collectives and 18 individuals recognized by the provincial drug administration and health commission [1]. - The Tai'an Food and Drug Inspection Institute received its first commendation from the National Adverse Drug Reaction Monitoring Center, indicating an improvement in the city's drug safety monitoring level [1]. Group 2: Future Strategies - The enhancement of drug safety monitoring will focus on quality improvement and efficiency, strengthening the monitoring system, and ensuring medical institutions fulfill their monitoring responsibilities [1]. - A "help + inspection" model will be implemented to improve the drug vigilance capabilities of drug license holders and medical institutions [1]. - The integration of risk prevention as a main line will involve enhancing technical support capabilities and utilizing both active and passive monitoring methods for comprehensive analysis [1]. - A public education initiative will be established through 27 drug safety publicity stations to foster community involvement in drug safety governance [1]. - Political construction will be emphasized to deepen the integration of party building and business, leading to high-quality development in drug safety monitoring [1]. Group 3: Participation - The meeting included over 150 participants, including experts in drug safety monitoring from medical institutions, regulatory officials, and monitoring staff from various levels of government [2].